Open Peer Review Reports for: Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
| Original Submission | ||
|---|---|---|
| 31 Aug 2016 | Submitted | Original manuscript |
| 16 Oct 2016 | Reviewed | Reviewer Report - Deng-Chyang Wu |
| 27 Oct 2016 | Reviewed | Reviewer Report - Wei-Chen Tai |
| 5 Nov 2016 | Author responded | Author comments - Diogo Branquinho |
| Resubmission - Version 2 | ||
| 5 Nov 2016 | Submitted | Manuscript version 2 |
| 22 Nov 2016 | Reviewed | Reviewer Report - Deng-Chyang Wu |
| 23 Nov 2016 | Reviewed | Reviewer Report - Wei-Chen Tai |
| 8 Dec 2016 | Author responded | Author comments - Diogo Branquinho |
| Resubmission - Version 3 | ||
| 8 Dec 2016 | Submitted | Manuscript version 3 |
| 4 Jan 2017 | Author responded | Author comments - Diogo Branquinho |
| Resubmission - Version 4 | ||
| 4 Jan 2017 | Submitted | Manuscript version 4 |
| Publishing | ||
| 11 Feb 2017 | Editorially accepted | |
| 15 Feb 2017 | Article published | 10.1186/s12876-017-0589-6 |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.
